Evidence map›Paper›PMID 26160393›Full record

ReviewEndocrine2015

Variability in laboratory parameters used for management of Cushing's syndrome.

Francesca Pecori Giraldi, Alberto G Ambrogio

Abstract readReview
In one paragraph

Review in Endocrine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Guideline
  2. Prospective Multicenter Evaluation of [Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2025
    Trial
  3. Article
  4. Article
  5. Unusual infections and thrombotic events in Cushing's syndrome.Journal of endocrinological investigation · 2025
    Review
  6. Endocrine disruptors, aryl hydrocarbon receptor and cortisol secretion.Journal of endocrinological investigation · 2024
    Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Diabetes in Cushing Disease.Current diabetes reports · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Francesca Pecori GiraldiDepartment of Clinical Sciences and Community Health, University of Milan, Milan, Italy. fpg@auxologico.it.
Alberto G AmbrogioNeuroendocrinology Research Laboratory, Istituto Auxologico Italiano, Via Zucchi 18, 20095, Milan, MI, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The progress in assay methodology, from the use of radioactive tracers to chemiluminescent signals, from competitive to chromatographic techniques and from serum or urine to saliva has considerably impacted on hormonal measurements. The clinician now may choose among multiple tests but the inherent variability in cortisol and ACTH secretion, coupled to lack of harmonization among assay procedures and normal ranges mandates careful interpretation of any result. The present review will examine factors which affect interpretation of cortisol and ACTH measurements and their impact on tests used for management of Cushing's syndrome.

Indexed as

Adrenocorticotropic HormoneCushing SyndromeDexamethasoneHumansHydrocortisoneSalivaAdrenocorticotropic HormoneDexamethasoneHydrocortisoneACTHAssayCortisolCushing’s diseaseCushing’s syndromeDiagnosis

Identifiers

PMID26160393
PMCPMC4662716

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.